Concepedia

Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations

Meytal Avgil Tsadok, Cynthia A. Jackevicius, E. Rahme, Vidal Essebag, Mark J. Eisenberg, Karin H. Humphries, Jack V. Tu, Hassan Behlouli, Ji Hyeon Joo, Louise Pilote

Canadian Medical Association Journal · 2011 · 26 citations · 20 references

DOIFull text

Open access

Abstract

In this population-based study, we saw no difference between brand-name and generic formulations of amiodarone in terms of incidence of thyroid dysfunction.

References

20

Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)

Joseph G. Hollowell, N Staehling, W. Dana Flanders et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 3.8K citations

, , +17

Amiodarone to Prevent Recurrence of Atrial Fibrillation

Denis‐Claude Roy, Mario Talajic, Paul Dorian et al. · New England Journal of Medicine · 2000 · 1.1K citations · Full text

Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)

Jennifer Hollowell · The Journal of Clinical Endocrinology & Metabolism · 2002 · 1K citations · Full text

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT

John A. Cairns, Stuart J. Connolly, Robin Roberts et al. · The Lancet · 1997 · 957 citations

, , +8

Age-Specific Distribution of Serum Thyrotropin and Antithyroid Antibodies in the U.S. Population: Implications for the Prevalence of Subclinical Hypothyroidism

Martin I. Surks, Joseph G. Hollowell · The Journal of Clinical Endocrinology & Metabolism · 2007 · 741 citations · Full text